# EDGAR Filing Document

**Accession Number:** 0001714576
**File Stem:** 0001104659-25-061241
**Filing Date:** 2025-6
**Character Count:** 38271
**Document Hash:** c512470b6d74761cfa7370028b5cf0ac
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-061241.hdr.sgml**: 20250620

**ACCESSION NUMBER**: 0001104659-25-061241

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250618

**FILED AS OF DATE**: 20250620

**DATE AS OF CHANGE**: 20250620

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BIOS Fund II QP, LP
- **CENTRAL INDEX KEY:** 0001716869

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40886
- **FILM NUMBER:** 251062453

**BUSINESS ADDRESS:**
- **STREET 1:** 1401 FOCH STREET
- **STREET 2:** SUITE 140
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
- **BUSINESS PHONE:** 817-984-5964

**MAIL ADDRESS:**
- **STREET 1:** 1401 FOCH STREET
- **STREET 2:** SUITE 140
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BIOS Memory SPV I, LP
- **CENTRAL INDEX KEY:** 0001643749

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40886
- **FILM NUMBER:** 251062456

**BUSINESS ADDRESS:**
- **STREET 1:** 1401 FOCH STREET, SUITE 140
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
- **BUSINESS PHONE:** 817-984-5964

**MAIL ADDRESS:**
- **STREET 1:** 1401 FOCH STREET, SUITE 140
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BIOS Fund I, LP
- **CENTRAL INDEX KEY:** 0001697316

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40886
- **FILM NUMBER:** 251062458

**BUSINESS ADDRESS:**
- **STREET 1:** 1401 FOCH STREET
- **STREET 2:** SUITE 140
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
- **BUSINESS PHONE:** 817-984-5964

**MAIL ADDRESS:**
- **STREET 1:** 1401 FOCH STREET
- **STREET 2:** SUITE 140
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BIOS Fund I QP, LP
- **CENTRAL INDEX KEY:** 0001700297

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40886
- **FILM NUMBER:** 251062457

**BUSINESS ADDRESS:**
- **STREET 1:** 1401 FOCH STREET, SUITE 140
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
- **BUSINESS PHONE:** 817-984-5964

**MAIL ADDRESS:**
- **STREET 1:** 1401 FOCH STREET, SUITE 140
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BIOS Fund II, LP
- **CENTRAL INDEX KEY:** 0001714576

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40886
- **FILM NUMBER:** 251062454

**BUSINESS ADDRESS:**
- **STREET 1:** 1401 FOCH STREET
- **STREET 2:** SUITE 140
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
- **BUSINESS PHONE:** 817-984-5964

**MAIL ADDRESS:**
- **STREET 1:** 1401 FOCH STREET
- **STREET 2:** SUITE 140
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BIOS Capital Management, LP
- **CENTRAL INDEX KEY:** 0001813845

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40886
- **FILM NUMBER:** 251062461

**BUSINESS ADDRESS:**
- **STREET 1:** 1751 RIVER RUN
- **STREET 2:** SUITE 400
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
- **BUSINESS PHONE:** 817-984-9197

**MAIL ADDRESS:**
- **STREET 1:** 1751 RIVER RUN
- **STREET 2:** SUITE 400
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Fletcher Aaron G.L.
- **CENTRAL INDEX KEY:** 0001789490

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40886
- **FILM NUMBER:** 251062462

**MAIL ADDRESS:**
- **STREET 1:** 40 GUEST STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02135
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Bios Equity Partners II, LP
- **CENTRAL INDEX KEY:** 0001813313

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40886
- **FILM NUMBER:** 251062455

**BUSINESS ADDRESS:**
- **STREET 1:** 1751 RIVER RUN, SUITE 400
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
- **BUSINESS PHONE:** 817-381-5370

**MAIL ADDRESS:**
- **STREET 1:** 1751 RIVER RUN, SUITE 400
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Bios Equity Partners, LP
- **CENTRAL INDEX KEY:** 0001813314

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40886
- **FILM NUMBER:** 251062459

**BUSINESS ADDRESS:**
- **STREET 1:** 1751 RIVER RUN, SUITE 400
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
- **BUSINESS PHONE:** 817-381-5370

**MAIL ADDRESS:**
- **STREET 1:** 1751 RIVER RUN, SUITE 400
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** BIOS Advisors GP, LLC
- **CENTRAL INDEX KEY:** 0001813844

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40886
- **FILM NUMBER:** 251062460

**BUSINESS ADDRESS:**
- **STREET 1:** 1751 RIVER RUN
- **STREET 2:** SUITE 400
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
- **BUSINESS PHONE:** 817-984-9197

**MAIL ADDRESS:**
- **STREET 1:** 1751 RIVER RUN
- **STREET 2:** SUITE 400
- **CITY:** FORT WORTH
- **STATE:** TX
- **ZIP:** 76107
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** COGNITION THERAPEUTICS INC
- **CENTRAL INDEX KEY:** 0001455365
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2403 SIDNEY STREET
- **STREET 2:** SUITE 261
- **CITY:** PITTSBURGH
- **STATE:** PA
- **ZIP:** 15203
- **BUSINESS PHONE:** 412-481-2210

**MAIL ADDRESS:**
- **STREET 1:** 2500 WESTCHESTER AVE
- **CITY:** PURCHASE
- **STATE:** NY
- **ZIP:** 10577

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** COGNITION THERAPUTICS INC
- **DATE OF NAME CHANGE:** 20090204

## Ex-24

**Exhibit 24**

**POWER OF ATTORNEY**

The undersigned hereby removes the following authority from Daniel Schwarz and, in his place, constitutes and appoints John Fucci and Troy Osborn, the lawful attorneys-in-fact and agents with full power and authority to execute and file on the undersigned's behalf, any and all instruments including Forms 3, 4 and 5, and Schedules 13D, 13G and 13F (collectively, the "Filings"), and any amendments, supplements or successor forms thereto pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any rules or regulations or requirements of the Securities and Exchange Commission in connection with the undersigned's reporting obligations with respect to securities of Cognition Therapeutics Inc., a Delaware corporation, pursuant to Section 13 of the Exchange Act and Section 16 of the Exchange Act.

The authority of such attorneys-in-fact shall continue until the undersigned is no longer required to file any of the Filings, unless earlier revoked in writing. The undersigned hereby ratifies, confirms and approves in all respects all Filings (including amendments thereto) and actions taken by any of the attorneys-in-fact relating to such Filings.

The undersigned acknowledges that the attorneys-in-fact are not assuming any of the undersigned's responsibilities to comply with Section 13 or Section 16 of the Exchange Act.

IN WITNESS WHEREOF, each of the undersigned has executed this Power of Attorney as of the date indicated.

Dated: June 20, 2025

---

| | |
|:---|:---|
| **BIOS MEMORY SPV I, LP** | **BIOS MEMORY SPV I, LP** |
| By: | Cavu Management, LP, |
|  | its general partner |

---

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By: | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By: | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS MEMORY SPV II, LP** | **BIOS MEMORY SPV II, LP** |
| By: | Bios Equity Partners, LP, |
|  | its general partner |

---

By: Cavu Management, LP, <br> its general partner

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr. |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS FUND I, LP** | **BIOS FUND I, LP** |
| By: | Bios Equity Partners, LP, |
|  | its general partner |

---

By: Cavu Management, LP, <br> its general partner

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr. |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS FUND I QP, LP** | **BIOS FUND I QP, LP** |
| By: | Bios Equity Partners, LP, |
|  | its general partner |

---

By: Cavu Management, LP, <br> its general partner

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS FUND II, LP** | **BIOS FUND II, LP** |
| By: | Bios Equity Partners II, LP, |
|  | its general partner |

---

By: Cavu Management, LP, <br> its general partner

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr. |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS FUND II QP, LP** | **BIOS FUND II QP, LP** |
| By: | Bios Equity Partners II, LP, |
|  | its general partner |

---

By: Cavu Management, LP, <br> its general partner

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS FUND II NT, LP** | **BIOS FUND II NT, LP** |
| By: | Bios Equity Partners II, LP, |
|  | its general partner |

---

By: Cavu Management, LP, <br> its general partner

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS FUND III, LP** | **BIOS FUND III, LP** |
| By: | Bios Equity Partners III, LP, |
|  | its general partner |

---

By: Cavu Management, LP, <br> its general partner

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS FUND III QP, LP** | **BIOS FUND III QP, LP** |
| By: | Bios Equity Partners III, LP, |
|  | its general partner |

---

By: Cavu Management, LP, <br> its general partner

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS FUND III NT, LP** | **BIOS FUND III NT, LP** |
| By: | Bios Equity Partners III, LP, |
|  | its general partner |

---

By: Cavu Management, LP, <br> its general partner

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS CLINICAL OPPORTUNITY FUND, LP** | **BIOS CLINICAL OPPORTUNITY FUND, LP** |
| By: | Bios Equity COF, LP, |
|  | its general partner |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BP Directors, LP** | **BP Directors, LP** |
| By: | Bios Equity Partners, LP, |
|  | its general partner |

---

By: Cavu Management, LP, <br> its general partner

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS EQUITY PARTNERS, LP** | **BIOS EQUITY PARTNERS, LP** |
| By: | Cavu Management, LP, |
|  | its general partner |

---

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS EQUITY PARTNERS II, LP** | **BIOS EQUITY PARTNERS II, LP** |
| By: | Cavu Management, LP, |
|  | its general partner |

---

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS EQUITY PARTNERS III, LP** | **BIOS EQUITY PARTNERS III, LP** |
| By: | Cavu Management, LP, |
|  | its general partner |

---

By: Cavu Advisors, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

By: Bios Capital Management, LP, <br> its general partner

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS EQUITY COF, LP** | **BIOS EQUITY COF, LP** |
| By: | Bios Capital Management, LP, |
|  | its general partner |

---

By: Bios Advisors GP, LLC, <br> its general partner

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| | |
|:---|:---|
| **CAVU MANAGEMENT, LP** | **CAVU MANAGEMENT, LP** |
| By: | Cavu Advisors, LLC, |
|  | its general partner |

---

---

| | |
|:---|:---|
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS CAPITAL MANAGEMENT, LP** | **BIOS CAPITAL MANAGEMENT, LP** |
| By: | Bios Advisors GP, LLC |
|  | its general partner |

---

---

| | |
|:---|:---|
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher |
|  | Manager |

---

---

| | |
|:---|:---|
| **CAVU ADVISORS, LLC** | **CAVU ADVISORS, LLC** |
| By*:* | /s/ Leslie Wayne Kreis, Jr. |
|  | Leslie Wayne Kreis, Jr., |
|  | Manager |

---

---

| | |
|:---|:---|
| **BIOS ADVISORS GP, LLC** | **BIOS ADVISORS GP, LLC** |
| By*:* | /s/ Aaron Glenn Louis Fletcher |
|  | Aaron Glenn Louis Fletcher, |
|  | Manager |

---

---

| |
|:---|
| /s/ Leslie Wayne Kreis, |
| **LESLIE WAYNE KREIS, JR., in his individual capacity** |

---

---

| |
|:---|
| /s/ Aaron Glenn Louis Fletcher |
| **AARON GLENN LOUIS FLETCHER, in his individual capacity** |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Fletcher Aaron G.L.<br><sub>(Last) (First) (Middle)</sub><br>C/O BIOS EQUITY PARTNERS<br>1751 RIVER RUN, SUITE 400<br><sub>(Street)</sub><br>FORT WORTH, TX 76107<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>COGNITION THERAPEUTICS INC [ CGTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BIOS Capital Management, LP<br><sub>(Last) (First) (Middle)</sub><br>C/O BIOS EQUITY PARTNERS<br>1751 RIVER RUN, SUITE 400<br><sub>(Street)</sub><br>FORT WORTH, TX 76107<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>COGNITION THERAPEUTICS INC [ CGTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BIOS Advisors GP, LLC<br><sub>(Last) (First) (Middle)</sub><br>C/O BIOS EQUITY PARTNERS<br>1751 RIVER RUN, SUITE 400<br><sub>(Street)</sub><br>FORT WORTH, TX 76107<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>COGNITION THERAPEUTICS INC [ CGTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Bios Equity Partners, LP<br><sub>(Last) (First) (Middle)</sub><br>C/O BIOS EQUITY PARTNERS<br>1751 RIVER RUN, SUITE 400<br><sub>(Street)</sub><br>FORT WORTH, TX 76107<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>COGNITION THERAPEUTICS INC [ CGTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BIOS Fund I, LP<br><sub>(Last) (First) (Middle)</sub><br>C/O BIOS EQUITY PARTNERS<br>1751 RIVER RUN, SUITE 400<br><sub>(Street)</sub><br>FORT WORTH, TX 76107<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>COGNITION THERAPEUTICS INC [ CGTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BIOS Fund I QP, LP<br><sub>(Last) (First) (Middle)</sub><br>C/O BIOS EQUITY PARTNERS<br>1751 RIVER RUN, SUITE 400<br><sub>(Street)</sub><br>FORT WORTH, TX 76107<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>COGNITION THERAPEUTICS INC [ CGTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BIOS Memory SPV I, LP<br><sub>(Last) (First) (Middle)</sub><br>C/O BIOS EQUITY PARTNERS<br>1751 RIVER RUN, SUITE 400<br><sub>(Street)</sub><br>FORT WORTH, TX 76107<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>COGNITION THERAPEUTICS INC [ CGTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Bios Equity Partners II, LP<br><sub>(Last) (First) (Middle)</sub><br>C/O BIOS EQUITY PARTNERS<br>1751 RIVER RUN, SUITE 400<br><sub>(Street)</sub><br>FORT WORTH, TX 76107<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>COGNITION THERAPEUTICS INC [ CGTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BIOS Fund II, LP<br><sub>(Last) (First) (Middle)</sub><br>C/O BIOS EQUITY PARTNERS<br>1751 RIVER RUN, SUITE 400<br><sub>(Street)</sub><br>FORT WORTH, TX 76107<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>COGNITION THERAPEUTICS INC [ CGTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>BIOS Fund II QP, LP<br><sub>(Last) (First) (Middle)</sub><br>C/O BIOS EQUITY PARTNERS<br>1751 RIVER RUN, SUITE 400<br><sub>(Street)</sub><br>FORT WORTH, TX 76107<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-18 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>COGNITION THERAPEUTICS INC [ CGTX ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-06-18 |  | A |  | 34000<sup>(1)</sup> | A | $0 | 48500 | D<sup>(2)</sup> |  |
| Common Stock |  |  |  |  |  |  |  | 500095 | I | By Bios Clinical Opportunity Fund, LP<sup>(6)(7)</sup> |
| Common Stock |  |  |  |  |  |  |  | 326733 | I | By Bios Fund III NT, LP<sup>(3)(4)(5)(7)</sup> |
| Common Stock |  |  |  |  |  |  |  | 2021906 | I | By Bios Fund III QP, LP<sup>(3)(4)(5)(7)</sup> |
| Common Stock |  |  |  |  |  |  |  | 309748 | I | By Bios Fund III, LP<sup>(3)(4)(5)(7)</sup> |
| Common Stock |  |  |  |  |  |  |  | 1424014 | I | By Bios Memory SPV I, LP<sup>(3)(4)(5)(7)</sup> |
| Common Stock |  |  |  |  |  |  |  | 418926 | I | By Bios Fund I, LP<sup>(3)(4)(5)(7)</sup> |
| Common Stock |  |  |  |  |  |  |  | 245029 | I | By Bios Fund I QP, LP<sup>(3)(4)(5)(7)</sup> |
| Common Stock |  |  |  |  |  |  |  | 78298 | I | By Bios Fund II, LP<sup>(3)(4)(5)(7)</sup> |
| Common Stock |  |  |  |  |  |  |  | 255765 | I | By Bios Fund II QP, LP<sup>(3)(4)(5)(7)</sup> |
| Common Stock |  |  |  |  |  |  |  | 34238 | I | By Bios Fund II NT, LP<sup>(3)(4)(5)(7)</sup> |
| Common Stock |  |  |  |  |  |  |  | 385248 | I | By Bios Memory SPV II, LP<sup>(3)(4)(5)(7)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 18, 2026 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to Aaron G.L. Fletcher's ("Dr. Fletcher") continuous service as a director as of the applicable vesting date.

(2) Pursuant to an agreement with BP Directors, LP ("Bios Directors"), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP ("Bios Equity I"), Cavu Management, LP ("Cavu Management"), Bios Capital Management, LP ("Bios Management"), Cavu Advisors LLC ("Cavu Advisors"), Bios Advisors GP, LLC ("Bios Advisors"), Leslie W. Kreis, Jr. ("Mr. Kreis") and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors.

(3) Bios Equity I is the general partner of the following entities: Bios Fund I, LP ("Bios Fund I"), Bios Fund I QP, LP ("Bios Fund I QP") and Bios Memory SPV II, LP ("Bios Memory II"). Bios Equity Partners II, LP ("Bios Equity II") is the general partner of the following entities: Bios Fund II, LP ("Bios Fund II"), Bios Fund II QP, LP ("Bios Fund II QP") and Bios Fund II NT, LP ("Bios Fund II NT. Bios Equity Partners III, LP ("Bios Equity III") is the general partner of the following entities: Bios Fund III, LP ("Bios Fund III"), Bios Fund III QP, LP ("Bios Fund III QP") and Bios Fund III NT, LP ("Bios Fund III NT").

(4) Bios Management and Cavu Management are the general partners of each of Bios Equity I, Bios Equity II, Bios Equity III and Bios Memory SPV I, LP ("Bios Memory I"). Bios Advisors is the general partner of Bios Management. Cavu Advisors is the general partner of Cavu Management. Bios Management and Bios Advisors are entities managed and controlled by Dr. Fletcher. Cavu Management and Cavu Advisors are entities managed and controlled by Mr. Kreis.

(5) Mr. Kreis, Cavu Management, Cavu Advisors, Dr. Fletcher, Bios Management and Bios Advisors each share voting and investment control with respect to the shares held by Bios Fund I, Bios Fund I QP, Bios Memory I, Bios Fund II, Bios Fund II QP, Bios Fund II NT, Bios Memory II, Bios Fund III, Bios Fund III QP and Bios Fund III NT (collectively, the "Bios Equity Entities"). Because of the relationship between Mr. Kreis, Mr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, Bios Advisors and the Bios Equity Entities, Mr. Kreis, Dr. Fletcher, Cavu Management, Bios Management, Cavu Advisors, and Bios Advisors each may be deemed to beneficially own the shares held directly by the Bios Equity Entities.

(6) Bios Equity COF, LP ("Bios Equity COF") is the general partner of Bios COF Fund. Bios Management is the general partner of Bios Equity COF. Dr. Fletcher, Bios Management and Bios Advisors each share voting and investment control with respect to the shares held by Bios COF Fund. Because of the relationship between Dr. Fletcher, Bios Management, Bios Advisors and Bios COF Fund, Dr. Fletcher, Bios Management and Bios Advisors may be deemed to beneficially own the shares held directly by Bios COF Fund.

(7) For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each reporting person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or otherwise.

**Remarks:**
Exhibit 24 - Power of Attorney

This Form 4 is the first of two Form 4 filings relating to the same event. The other Form 4 relating to the same event was filed by Mr. Kreis as the designated filer. The Form 4 has been split into two filings because there are more than 10 reporting persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 reporting persons.

**Signature:** Aaron G.L. Fletcher By: /s/ John Fucci, as attorney-in-fact  
**Date:** 2025-06-20

**Signature:** Bios Capital Management, LP By: Bios Advisors GP, LLC, its general partner By: /s/ John Fucci, as attorney-in-fact  
**Date:** 2025-06-20

**Signature:** Bios Advisors GP, LLC By: /s/ John Fucci, as attorney-in-fact  
**Date:** 2025-06-20

**Signature:** Bios Equity Partners, LP By: Bios Capital Management, LP, its general partner By: Bios Advisors GP, LLC, its general partner By: /s/ John Fucci, as attorney-in-fact  
**Date:** 2025-06-20

**Signature:** Bios Fund I, LP By: Bios Equity Partners, LP, its general partner By: Bios Capital Management, LP, its general partner By: Bios Advisors GP, LLC, its general partner By: /s/ John Fucci, as attorney-in-fact  
**Date:** 2025-06-20

**Signature:** Bios Fund I QP, LP By: Bios Equity Partners, LP, its general partner By: Bios Capital Management, LP, its general partner By: Bios Advisors GP, LLC, its general partner By: /s/ John Fucci, as attorney-in-fact  
**Date:** 2025-06-20

**Signature:** Bios Memory SPV I, LP By: Bios Equity Partners, LP, its general partner By: Bios Capital Management, LP, its general partner By: Bios Advisors GP, LLC, its general partner By: /s/ John Fucci, as attorney-in-fact  
**Date:** 2025-06-20

**Signature:** Bios Equity Partners II, LP By: Bios Capital Management, LP, its general partner By: Bios Advisors GP, LLC, its general partner By: /s/ John Fucci, as attorney-in-fact  
**Date:** 2025-06-20

**Signature:** Bios Fund II, LP By: Bios Equity Partners II, LP, its general partner By: Bios Capital Management, LP, its general partner By: Bios Advisors GP, LLC, its general partner By: /s/ John Fucci, as attorney-in-fact  
**Date:** 2025-06-20

**Signature:** Bios Fund II QP, LP By: Bios Equity Partners II, LP, its general partner By: Bios Capital Management, LP, its general partner By: Bios Advisors GP, LLC, its general partner By: /s/ John Fucci, as attorney-in-fact  
**Date:** 2025-06-20

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**